Observational studyScientific reports2022

Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease.

Takahiro Amano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.